Recent research suggests that psilocybin promotes the growth of neurons in the brain, but is it enough to repair extreme brain damage? Some claim it can, and we’ll have more insights soon!
Wesana Health (WESA) began conducting functional animal studies to test a psilocybin-based regimen on traumatic brain injury (TBI) and is expecting to have results by the end of the year. The studies will examine the effect of different combinations of doses on locomotor activity, as well as on anxiety and depression, which are common side effects of brain injuries.
The company recently completed a preliminary study on TBI, anxiety and depression related to TBI, and migraines unrelated to TBI, and will complete a pivotal study based on the findings by the end of September.